Business & Regulation

Business & Regulation Standards & Regulation

The Trump Effect on Biopharma: FDA Disruption, Tariffs, and Funding Cuts

05/09/2025 | 5 min read

Trump continues to send shockwaves through the industry. We look at FDA disruption, tariffs, funding volatility, and more.

Business & Regulation Profession

Denmark and Sweden Invite Misplaced US Scientists to the EU

05/08/2025 | Rob Coker | 2 min read

Many US researchers are at odds with the imposition of Trump’s political agendas. EU member states are looking to take advantage.

Business & Regulation Standards & Regulation

This Week’s Biopharma News: EU Launches Initiative to Attract Scientists from US

05/07/2025 | Stephanie Vine | 4 min read

Our latest news roundup reports on Novartis’ new acquisition, an NIH grant for an Alzheimer’s disease vaccine, and more

Business & Regulation Bioprocessing - Upstream & Downstream

The Power List Personified: Getting to Know Beatrice Lavery

05/16/2025 | Rob Coker | 4 min read

Now that the 2025 Power List is live, we speak with the people working hard every day to make a difference.

Business & Regulation Advanced Medicine

This Week’s Biopharma News: Long-Running CRISPR Patent Case Reopened

05/15/2025 | Rob Coker | 4 min read

Our latest roundup reports on Trump's “most favored nation” order, an EMA investigation into finasteride, and Novo Nordisk’s continued R&D for obesity

Business & Regulation Standards & Regulation

US States Sue Over RFK Jr’s HHS Layoffs and Reorganization

05/06/2025 | Stephanie Vine | 3 min read

Attorney Generals claim: “This administration is not streamlining the federal government; they are sabotaging it.”

Business & Regulation Profession

Starting a Business in CRISPR

05/02/2025 | Stephanie Vine | 8 min read

From a love of history books to a love of CRISPR, Monika Paule tells us the story of her career and the origins of Caszyme.

Business & Regulation Business Practice

Breaking Down Brain Barriers

04/29/2025 | Agnese Cattaneo | 3 min read

As mental health disorders escalate, pharmaceutical innovators can harness advanced tools to accelerate much-needed treatments.

Business & Regulation Profession

Medicine Making Pioneers

04/24/2025 | Stephanie Vine

From Carl June to Peter Marks to Kiran Mazumdar-Shaw; check out our thought provoking interviews with some of the biggest names in the pharma field.

Business & Regulation Trends & Forecasts

This Week’s Biopharma News: Roche’s $50 Billion Investment in the US and More

04/24/2025 | 4 min read

Our latest news roundup reports on Roche’s US investment, a lawsuit against Vertex Pharmaceuticals, and more.

Business & Regulation Trends & Forecasts

Quality Over Quantity: EMA's New Approach to Biosimilars

04/23/2025 | Rob Coker | 2 min read

EMA reflection paper considers elimination of routine comparative efficacy studies for biosimilars.

Business & Regulation Standards & Regulation

Trump's New Push on Drug Pricing

04/21/2025 | Rob Coker | 2 min read

Trump signs executive order on lowering drug prices and amends Medicare price negotiation for small molecule drugs.

Business & Regulation Profession

From Benchtop Chemist to CEO

04/17/2025 | Stephanie Vine | 5 min read

Simon Tasker joined Colorcon as a bench chemist – and never left. Today, he’s the company’s CEO. Here’s how his career unfolded.